Veterinary Pain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Product (Medications v/s Medical Devices), By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others), By Animal Type (Companion Animal v/s Livestock Animal), By Region and Competition

Global veterinary pain management market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing incidence of inflammatory and painful diseases such as deficiency disease, hereditary diseases, and physiological diseases in the animal population. Additionally, growing the need for easily accessible and affordable treatment procedures in the urban regions and growing awareness about animal health and welfare have significantly enhanced the demand for veterinary pain management across different parts of the globe. Additionally, increasing in the livestock population suffering from cancer, abdominal pain and neuropathic pain is expected to boost the demand for different veterinary pain management, thereby fuelling the market growth through 2028. Besides, increasing research and development activities to treat various causes of pain in animals including different therapy across the globe is further expected to support the veterinary pain management market during the forecast period. According to an article published by Veterinary Practice News in June 2020, the prevalence of osteoarthritis in dogs was found to be 20% globally. Similarly, according to an article published by American Animal Health Association in April 2021, approximately 6 million dogs are diagnosed with cancer each year. 

There is a growing awareness among pet owners about animal welfare, which has led to an increased demand for pain management products and services to ensure that their pets are comfortable and pain-free. Many pet owners are not aware of the importance of pain management for their pets. This lack of awareness can lead to underdiagnosis and undertreatment of pain in pets, which can negatively impact the growth of the market. The cost of veterinary pain management products and services can be relatively high, which can limit their accessibility to pet owners, particularly in developing countries. Some pain management drugs may have side effects that can be harmful to pets. This can lead to safety concerns among pet owners, which can negatively impact the growth of the market. There is a shortage of pain management specialists in the veterinary field, which can limit the availability of specialized pain management services. The development and approval of pain management products for veterinary use are subject to stringent regulatory requirements, which can be time-consuming and costly. Alternative therapies, such as acupuncture and herbal remedies, are becoming increasingly popular among pet owners as an alternative to traditional pain management products and services. This can impact the growth of the market. The advantages of veterinary pain management are numerous, and they are essential for maintaining the health and well-being of our animal companions.

Growing Prevalence of Chronic Diseases

Increasing rate of acute and chronic diseases in animals across the globe is one of the major factors bolstering the growth of the market in the forecast period. For example, growing incidence rate of infectious diseases such as deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases) and physiological diseases in animals is positively enhancing the growth of the market over the coming years. Also, due to the increasing prevalence of animal diseases which also includes epizootic diseases, there is a greater awareness and rising need of veterinary pain management therapy. Seventy percent of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Similarly, the growing need for outpatient clinics to meet the rising volume of surgical procedures is expected to create significant growth during the forecasted period. Chronic diseases such as osteoarthritis, cancer, and periodontal diseases are becoming more common in pets, leading to an increase in demand for pain management products. With the rise in demand for minimally invasive surgeries in veterinary medicine, the need for effective pain management has also increased. The growing number of pet owners worldwide has led to an increase in demand for veterinary pain management products and services. The Assisi Loop: This is a non-invasive device that uses targeted pulsed electromagnetic field therapy (tPEMF) to manage pain and inflammation in pets. It can be used for a variety of conditions, including osteoarthritis, post-surgical pain, and wounds. The Theraplate: This is a vibration therapy platform that is designed to improve circulation, reduce inflammation, and promote healing in pets. It can be used for a variety of conditions, including musculoskeletal pain, laminitis, and soft tissue injuries. There are several approaches to managing pain in pets, including Medications such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and gabapentin can be used to manage pain in pets. However, it is important to note that some medications can have side effects and should be used under the guidance of a veterinarian. Non-pharmacological therapies such as acupuncture, massage, and physical therapy can be used to manage pain in pets. These therapies can be used alone or in combination with medications. Proper nutrition can play a role in managing pain in pets, particularly in cases of chronic conditions such as arthritis. Specialized diets that contain ingredients such as glucosamine and chondroitin can help improve joint health and reduce pain.

Increasing Investment in the Pet Healthcare Sector

Growing focus towards improving the pet healthcare facilities and overall healthcare infrastructure is a major factor boosting the growth of the veterinary pain management market in the forecast period. In order to develop and apply new and improved technologies, there are an increasing number of strategic partnerships and collaborations with both public and private organisations. This is further expanding the diversity of market opportunities for the coming years. Additionally, the government's rising efforts to raise awareness of the value of early diagnosis are once again fuelling the market's expansion. Increasing investment in R&D, particularly in established and developing economies, in relation to medical instruments and devices will further generate profitable market expansion prospects over the projection period. The total number of pets insured in the U.S. at 2021 was 3.9 million, a 28 percent increase since 2020. Also, the growing popularity of nonpharmaceutical pain management techniques is a major factor in the growth of the market, and the growing demand for laser therapy and electromagnetic therapy as pain management is anticipated to drive the growth of the market over the years. The Game Ready Vet System: This is a cold and compression therapy system that can be used to manage pain and swelling in pets. It can be used for a variety of conditions, including post-surgical pain, soft tissue injuries, and arthritis. The RLT Veterinary Bed: This is a therapeutic bed that uses red light therapy to manage pain, reduce inflammation, and promote healing in pets. It can be used for a variety of conditions, including arthritis, hip dysplasia, and post-surgical pain. The government initiatives aimed at improving animal health and welfare have led to the growth of the veterinary pain management market. For example, several countries have regulations that require veterinarians to provide pain management for their patients. There is a growing interest in non-pharmacological pain management techniques, such as acupuncture, physical therapy, and massage, as alternative or complementary therapies to traditional pain management drugs. Several pain assessment tools have been developed for use in veterinary medicine, such as the Glasgow Composite Measure Pain Scale (CMPS) and the University of Melbourne Pain Scale (UMPS), to help veterinarians better diagnose and manage pain in their patients. Advances in surgical pain management techniques, such as the use of preemptive analgesia and regional anesthesia, are leading to improved pain management outcomes in pets undergoing surgery. Vetdrop works by using a process called transdermal absorption, which allows the active ingredients in the solution to penetrate the skin and reach the underlying tissue. The solution is applied to the skin using a specially designed applicator, which allows for targeted delivery of the solution to the affected area. One of the benefits of Vetdrop is its non-invasive nature, which means that it can be used as an alternative to traditional pain management approaches that rely on medications or invasive procedures. Additionally, Vetdrop is easy to use and can be administered by veterinary professionals or pet owners themselves.

Recent Development

• In February 2021, Dechra Pharmaceuticals PLC received rights for marketing Tri-Solfen in Australia and New Zealand under a licensing agreement with Animal Ethics Pty Ltd. Tri-Solfen is used as a routine treatment in reducing pain for farm animals.
• In July 2020, Boehringer Ingelheim acquired a Belgian biotech company, GST, to strengthen its stem cell capabilities in the Animal Health segment.

Download Free Sample Report

Market Segmentation

Global veterinary pain management market can be segmented by product, by application, by animal type and by region. Based on product, the market can be divided into Medications and Medical Devices. Based on application, the market can be differentiated into Joint Pain, Cancer Pain, Postoperative Pain, Others. Based on application, the market can be divided into Companion Animal and Livestock Animal. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East and Africa and South America. Among the different countries, United States dominated the global veterinary pain management market on account of growing incidence of animal diseases in the country.

Market Players

Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Norbrook Laboratories Limited, SeQuent Scientific Limited, Merck & Co., Inc., Dechra Pharmaceuticals Plc, Vetoquinol S.A., Ceva Santé Animale SA, Chanelle Pharma Group Ltd are some of the leading players operating in the global veterinary pain management market.

Report Scope:

In this report, global veterinary pain management market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Veterinary Pain Management Market, By Product:

o    Medications

o    Medical Devices

• Veterinary Pain Management Market, By Application:

o    Joint Pain

o    Cancer Pain

o    Postoperative Pain

o    Others

• Veterinary Pain Management Market, By Animal Type:

o    Companion Animal

o    Livestock Animal

• Veterinary Pain Management Market, By Region:
• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• South Korea
• Japan
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Egypt
• Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Veterinary Pain Management Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Pain Management Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]